Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Ending Cash Position : ¥213 Mil (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Henan Taloph Pharmaceutical Stock Co Ending Cash Position?

Henan Taloph Pharmaceutical Stock Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥213 Mil.

Henan Taloph Pharmaceutical Stock Co's quarterly Ending Cash Position increased from Sep. 2023 (¥146 Mil) to Dec. 2023 (¥175 Mil) and increased from Dec. 2023 (¥175 Mil) to Mar. 2024 (¥213 Mil).

Henan Taloph Pharmaceutical Stock Co's annual Ending Cash Position declined from Dec. 2021 (¥330 Mil) to Dec. 2022 (¥255 Mil) and declined from Dec. 2022 (¥255 Mil) to Dec. 2023 (¥175 Mil).

Henan Taloph Pharmaceutical Stock Co Ending Cash Position Historical Data

The historical data trend for Henan Taloph Pharmaceutical Stock Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Taloph Pharmaceutical Stock Co Ending Cash Position Chart

Henan Taloph Pharmaceutical Stock Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

393.16

487.32

330.24

254.72

175.00

Henan Taloph Pharmaceutical Stock Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															191.80	140.92	146.31	175.00	213.27

Henan Taloph Pharmaceutical Stock Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Henan Taloph Pharmaceutical Stock Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	254.721	+	-79.717
	=	175

Henan Taloph Pharmaceutical Stock Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	182.929	+	30.343
	=	213

Henan Taloph Pharmaceutical Stock Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Henan Taloph Pharmaceutical Stock Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Taloph Pharmaceutical Stock Co Ltd (SHSE:600222) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

No. 8, Jinsuo Road, High-tech Industrial Development Zone, Henan Province, Zhengzhou, CHN, 450001

Website

http://www.taloph.com

Henan Taloph Pharmaceutical Stock Co Ltd is a Chinese company engaged in the manufacture of Western and Chinese medicine products, including oral liquids, tablets, capsules, and bulk drugs. Geographically, the business activities are functioned through China region.

Executives

Zhao Qing Xin

Director

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Headlines

No Headlines